Related Experiment Video
Updated: Jan 8, 2026

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials
Published on: March 3, 2023
Antimicrobial Management Strategies for Multidrug-Resistant Gram-Positive Prosthetic Device Infections
Burcu Isler1, Peter Simos2, Victoria Grey3
1Department of Infectious Diseases, Gold Coast University Hospital, 1 Hospital Boulevard, Southport 4215, Gold Coast, QLD, Australia; Faculty of Health, Medicine & Behavioural Sciences, University of Queensland Centre for Clinical Research, Brisbane, Australia; School of Medicine and Dentistry, Griffith University, Gold Coast, Australia.
Abstract:
Prosthetic device infections caused by multidrug-resistant (MDR) gram-positive bacteria pose significant therapeutic challenges. This review examines management strategies for methicillin-resistant staphylococci, ampicillin-resistant enterococci, vancomycin-resistant enterococci, and MDR Corynebacterium infections. Success requires coordinated surgical intervention and antimicrobial therapy, with device removal often necessary. Vancomycin remains the cornerstone for most resistant organisms, while newer agents like dalbavancin enable outpatient therapy. Critical considerations include recognizing linezolid toxicity during prolonged therapy, and understanding that surgical approach determines outcomes more than antimicrobial selection.
Insights
Managing multidrug-resistant (MDR) gram-positive prosthetic device infections requires surgery and antibiotics. Device removal is often key, with vancomycin a primary treatment, and newer drugs allowing outpatient care.
Area of Science:
- Infectious Diseases
- Medical Microbiology
- Surgical Infections
Background:
- Prosthetic device infections (PDIs) caused by multidrug-resistant (MDR) gram-positive bacteria present complex clinical challenges.
- Key pathogens include methicillin-resistant staphylococci, ampicillin-resistant enterococci, vancomycin-resistant enterococci, and MDR Corynebacterium species.
Purpose of the Study:
- To review current management strategies for PDIs caused by specific MDR gram-positive bacteria.
- To highlight the interplay between surgical intervention and antimicrobial therapy.
Main Methods:
- Literature review of management strategies for PDIs.
- Analysis of antimicrobial options and surgical considerations.
Main Results:
- Successful management necessitates a combined approach of surgical intervention and appropriate antimicrobial therapy.
- Device removal is frequently essential for successful treatment outcomes.
- Vancomycin is a cornerstone antimicrobial, while agents like dalbavancin offer outpatient treatment possibilities.
- Linezolid use requires monitoring for toxicity during extended therapy.
Conclusions:
- Surgical approach significantly influences outcomes, often more than antimicrobial choice alone.
- Coordinated multidisciplinary care is critical for optimizing PDI management.
- Emerging therapies provide new avenues for treating challenging PDI cases.
Related Concept Videos
Endocarditis III: Medical Management
Acute Pyelonephritis II: Diagnostic Studies and Management
Endocarditis IV: Nursing Management
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Mitral Stenosis III: Medical Management
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

